Ani Pharmaceuticals (ANIP) Income towards Parent Company (2011 - 2026)
Ani Pharmaceuticals' (ANIP) quarterly Income towards Parent Company came in at $24.7 million in Q2 2026, up 189.7% year-over-year from $8.5 million in Q2 2025, and down 16.26% quarter-over-quarter from $29.5 million in Q1 2026.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Income towards Parent Company (2011 - 2026) Analysis & Trends
Ani Pharmaceuticals has disclosed Income towards Parent Company across 16 years of filings, most recently posting $24.7 million for Q2 2026.
- In Q2 2026, Income towards Parent Company rose 189.7% year-over-year to $24.7 million; the TTM figure through Jun 2026 stood at $108.3 million (up 1158.17% YoY), while the FY2025 annual figure was $78.3 million, up 522.94% from the prior year.
- Income towards Parent Company came in at $24.7 million for Q2 2026 at Ani Pharmaceuticals, down from $29.5 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $29.5 million in Q1 2026 to a low of -$24.2 million in Q3 2024.
- Average Income towards Parent Company over 5 years is $4.7 million, with a median of $3.9 million recorded in 2023.
- Year-over-year, Income towards Parent Company plunged 18372.73% in 2022 and soared 1135.21% in 2024.
- Over 5 years, Income towards Parent Company stood at -$4.3 million in 2022, then soared by 127.12% to $1.2 million in 2023, then plunged by 989.7% to -$10.3 million in 2024, then jumped by 367.86% to $27.5 million in 2025, then fell by 10.27% to $24.7 million in 2026.
- Per Business Quant data, the three most recent Income towards Parent Company figures were $24.7 million in Q2 2026, $29.5 million in Q1 2026, and $27.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn |
| 10 | NutriBand | 94.45 Mn | 91.03 Mn | 181,874.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.70 Mn |
| Mar 31, 2026 | 29.49 Mn |
| Dec 31, 2025 | 27.53 Mn |
| Sep 30, 2025 | 26.60 Mn |
| Jun 30, 2025 | 8.53 Mn |
| Mar 31, 2025 | 15.68 Mn |
| Dec 31, 2024 | -10.28 Mn |
| Sep 30, 2024 | -24.17 Mn |
| Jun 30, 2024 | -2.29 Mn |
| Mar 31, 2024 | 18.21 Mn |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 9.91 Mn |
| Jun 30, 2023 | 6.25 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | -4.26 Mn |
| Sep 30, 2022 | -8.60 Mn |
| Jun 30, 2022 | -14.92 Mn |
| Mar 31, 2022 | -20.10 Mn |
| Dec 31, 2021 | -24.14 Mn |
| Sep 30, 2021 | -4.43 Mn |
API Access
Ani Pharmaceuticals Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=ANIP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();